News

ACCOMPLISH in New England Journal of Medicine

December 05, 2008
The ACCOMPLISH study demonstrated that a combination of benazepril and amlodipine was superior to the combination of benazepril and hydrochlorotizide in reducing cardiovascular events in patients with hypertension who were at risk for such events.

60% of all clinical trials miss their deadlines

October 23, 2008
And more than 80% of the delays are due to poor patient recruitment.

Thank you for making it a successful housewarming!

October 20, 2008
Thank you everyone for coming and celebrating our new office location with us in Lund, October 16th. We had fun networking with clients, friends and former colleagues!

Gothenburg office houses GCP theme day

September 15, 2008
In the beginning of September, one of four GCP theme days, organized by the Swedish Academy of Pharmaceutical Sciences, took place at A+ Science offices in Gothenburg. About 80 people attended seminars headed by several interesting speakers, among others Gunnar Danielsson from the MPA.

2 500 cardiologists attends accredited CME

September 10, 2008
Continuing medical education (CME) help professionals in the medical field maintain competence and learn about new and developing areas of their field. CME often takes place as live events headed by highly renowned researchers and opinion leaders.

Vita Nova Group acquires NMCT’s patient recruitment

June 25, 2008
A+ Science AB, the subsidiary company of Vita Nova Ventures has today reached an agreement to acquire part of the business activities in the bankrupt estate of NMCT AB in Gothenburg.

Meet us at Hypertension 2008

June 10, 2008
The Hypertension 2008 expects 7 000 participants from the Life Science Industry. The meeting offers a program with the latest results in the field of hypertension and many exhibitors showing off their latest news.

The Stockholm offices have moved

June 02, 2008
On Monday June 2nd 2008 A+ Science’s two Stockholm offices merged into one at Solna Business Park.

The Allay trial at ACC08

April 15, 2008
During the Annual American College of Cardiology 2008 Scientific Sessions, (ACC 08) held in Chicago in March, another successful study, the ALLAY Trial, was presented. A+ Science has been responsible for the ECG handling and coding of all ALLAY ECGs.

Preliminary results ACCOMPLISH trial

April 02, 2008
Preliminary results of the ACCOMPLISH Trial show that a combination therapy with ACE inhibitor plus calcium –channel blocker is more effective than a treatment with the ACE inhibitor plus diuretic.

Breakfast meeting May 19, 2008

March 27, 2008
in Swedish only.

Upcoming news in cardiovascular and metabolic diseases

March 26, 2008
ALLAY is the largest study on regression of left ventricular hypertrophy with MRI technique and included over 400 patients in seven countries from all over the world. ACCOMPLISH is a comparison study of two fixed combination drugs (more below) and included over 11 000 patients in six countries.

City Site - a new Clinical Research unit

February 04, 2008
A+ Science Clinical Services AB launches a Clinical Pharmaceutical Research unit in the heart of Stockholm. The doors open up today in one of the tall buildings located at Hötorget on Sveavägen 17. The research unit, A+ Science City Site, will be conducting clinical trials within many different therapeutic fields. The unit is well equipped and accessible for patient recruitment within a very short time. A+ Science specializes in clinical trials and through this specialization it promises a faster accomplishment and top quality trials. The clients are pharmaceutical companies, medical device companies and individual researchers.

Clinical trial symposium held in Morocco

January 17, 2008
A+ Science played an important part in a clinical trial symposium held at the Faculty of Medicine in Marrakech Morocco. The discussion centered on how Morocco could become a competitive player in the area of clinical trials. The collaboration between A+ Science and several key representatives from authorities, Ethics Committee, universities and interest groups managed to reveal issues needing attention as well as promising opportunities; knowledge that given time and collaboration could make Morocco an important contributor to clinical research.

Upcoming events


Copyright © 1997-2009 A+ Science AB. or its subsidiaries. All rights reserved.